Cell and organ bioengineering technology as applied to gastrointestinal diseases

Gut

Volumn 62, Issue 5, 2013, Pages 774-786

  Orlando, Giuseppe ^a   Bendala, Juan Domínguez ^b   Shupe, Thomas ^a   Bergman, Christopher ^a   Bitar, Khalil N ^a   Booth, Christopher ^a   Carbone, Marco ^c   Koch, Kenneth L ^a   Lerut, Jan P ^d   Neuberger, James M ^c   Petersen, Bryon ^a   Ricordi, Camillo ^b   Atala, Anthony ^a   Stratta, Robert J ^a   Soker, Shay ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOENGINEERING; CELL DIFFERENTIATION; CELL ENGINEERING; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL POPULATION; CELL VIABILITY; CLINICAL EFFECTIVENESS; ESOPHAGUS REGENERATION; EXTRACELLULAR MATRIX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; HUMAN; LIVER REGENERATION; MESENCHYMAL STEM CELL; NONHUMAN; ORGAN BIOENGINEERING; PANCREAS REGENERATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SMALL INTESTINE REGENERATION; STEM CELL TRANSPLANTATION; STOMACH REGENERATION; TISSUE REGENERATION; TREATMENT INDICATION;

BIOENGINEERING; GASTROINTESTINAL DISEASES; HUMANS; INTESTINAL DISEASES; LIVER FAILURE; LIVER REGENERATION; LIVER TRANSPLANTATION; ORGAN TRANSPLANTATION; PANCREATIC DISEASES; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84875818160     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301111     Document Type: Article

References (136)

1. Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med 2008;3:1-5. (Pubitemid 351541190)
2. Orlando G, Baptista P, Birchall M, et al. Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int 2011;24:223-32.
3. Orlando G, Wood KJ, Stratta RJ, et al. Regenerative medicine and organ transplantation: past, present, and future. Transplantation 2011;91:1310-17.
4. Orlando G, Wood KJ, De Coppi P, et al. Regenerative medicine as applied to general surgery. Ann Surg In press.
5. Orlando G, Wood KJ, Soker S, et al. How regenerative medicine may contribute to the achievement of an immunosuppressionfree state. Transplantation 2011;92:-36-8.
6. Shinoka T, Imai Y, Ikada Y. Transplantation of a tissueengineered pulmonary artery. N Engl J Med 2001;344:532-3.
7. Shinoka T, Matsumura G, Hibino N, et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005;129:1330-8.
8. Hibino N, McGillicuddy E, Matsumura G, et al. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 2010;139:431-6.
9. McAllister TN, Maruszewski M, Garrido SA, et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009;373:1440-6.
10. L'Heureux N, McAllister TN, de la Fuente LM. Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med 2007;357:1451-3. (Pubitemid 47535609)
11. Atala A, Bauer SB, Soker S, et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006;367:1241-6.
12. Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008;372:2023-30.
13. Baiguera S, Birchall MA, Macchiarini P. Tissue-engineered tracheal transplantation. Transplantation 2010;89:485-91.
14. Macchiarini P, Walles T, Biancosino C, et al. First human transplantation of a bioengineered airway tissue. J Thorac Cardiovasc Surg 2004;128:638-41. (Pubitemid 39278409)
15. Walles T, Biancosino C, Zardo P, et al. Tissue remodeling in a bioartificial fibromuscular patch following transplantation in a human. Transplantation 2005;80:284-5. (Pubitemid 41061691)
16. Raya-Rivera A, Esquiliano DR, Yoo JJ, et al. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet 2011;377:1175-82.
17. Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-21. (Pubitemid 351214548)
18. Eitan Y, Sarig U, Dahan N, et al. Acellular cardiac extracellular matrix as a scaffold for tissue engineering: in vitro cell support, remodeling, and biocompatibility. Tissue Eng Part C Methods 2010;16:671-83.
19. Wainwright JM, Czajka CA, Patel UB, et al. Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng Part C Methods 2010;16:525-32.
20. Uygun BE, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010;16:814-20.
21. Baptista PM, Siddiqui MM, Lozier G, et al. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011;53:604-17.
22. Shupe T, Williams M, Brown A, et al. Method for the decellularization of intact rat liver. Organogenesis 2010;6:134-6.
23. Wang Y, Cui CB, Yamauchi M, et al. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissuespecific biomatrix scaffolds. Hepatology 2011;53:293-305.
24. Soto-Gutierrez A, Zhang L, Medberry C, et al. A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods 2011;17:677-86.
25. Petersen TH, Calle EA, Zhao L, et al. Tissue-engineered lungs for in vivo implantation. Science 2010;29:538-41.
26. Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010;16:927-33.
27. De Carlo E, Baiguera S, Conconi MT, et al. Pancreatic acellular matrix supports islet survival and function in a synthetic tubular device: in vitro and in vivo studies. Int J Mol Med 2010;25:195-202.
28. Grikscheit TC, Siddique A, Ochoa ER, et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 2004;240:748-54. (Pubitemid 39425765)
29. Grikscheit TC, Ochoa ER, Ramsanahie A, et al. Tissueengineered large intestine resembles native colon with appropriate in vitro physiology and architecture. Ann Surg 2003;238:35-41. (Pubitemid 38176405)
30. Mertsching H, Schanz J, Steger V, et al. Generation and transplantation of an autologous vascularized bioartificial human tissue. Transplantation 2009;88:203-10.
31. Ross EA, Williams MJ, Hamazaki T, et al. Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol 2009;20:2338-47.
32. Nakayama KH, Batchelder CA, Lee CI, et al. Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng Part A 2010;16:2207-16.
33. Liu CX, Liu SR, Xu AB, et al. [Preparation of whole-kidney acellular matrix in rats by perfusion] (In Chinese). Nan Fang Yi Ke Da Xue Xue Bao 2009;29:979-82.
34. Kmie-c Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001;161:IIIeXIII, 1-151.
35. Kay MA, Fausto N. Liver regeneration: prospects for therapy based on new technologies. Mol Med Today 1997;3:108-15. (Pubitemid 28119276)
36. Kwon AH, Matsui Y, Ha-Kawa SK, et al. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol 2001;96:541-6.
37. Meng F, Francis H, Glaser S, et al. Role of stem cell factor and granulocyte-colony stimulating factor in remodeling during liver regeneration. Hepatology 2012;55:209-21.
38. Cardinale V, Wang Y, Carpino G, et al. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes and pancreatic islets. Hepatology 2011;54:2159-72.
39. Turner R, Lozoya O, Wang Y, et al. Human hepatic stem cell and maturational liver lineage biology. Hepatology 2011;53:1035-45.
40. Kuver R, Savard CE, Lee SK, et al. Murine gallbladder epithelial cells can differentiate into hepatocyte-like cells in vitro. Am J Physiol Gastrointest Liver Physiol 2007;293:G944-55. (Pubitemid 350106572)
41. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168-70. (Pubitemid 29288406)
42. Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology 2000;32:11-16. (Pubitemid 30432360)
43. Alison MR, Poulsom R, Jeffery R, et al. Hepatocytes from nonhepatic adult stem cells. Nature 2000;406:257. (Pubitemid 30604395)
44. Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006;24:2292-8. (Pubitemid 44527483)
45. Mohamadnejad M, Namiri M, Bagheri M, et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 2007;13:3359-63. (Pubitemid 47062247)
46. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007;10:459-66. (Pubitemid 350001896)
47. Piscaglia AC, Shupe TD, Oh SH, et al. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology 2007;133:619-31. (Pubitemid 47187344)
48. Gaia S, Smedile A, Omedé P, et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006;45:13-19. (Pubitemid 43850621)
49. Di Campli C, Zocco MA, Saulnier N, et al. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. Dig Liver Dis 2007;39:1071-6. (Pubitemid 350131542)
50. Spahr L, Lambert JF, Rubbia-Brandt L, et al. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology 2008;48:221-9. (Pubitemid 351975547)
51. Pai M, Zacharoulis D, Milicevic MN, et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 2008;103:1952-8.
52. Salama H, Zekri AR, Bahnassy AA, et al. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol 2010;16:5297-305.
53. Aurich I, Mueller LP, Aurich H, et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 2007;56:405-15. (Pubitemid 46579773)
54. Chamberlain J, Yamagami T, Colletti E, et al. Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep. Hepatology 2007;46:1935-45.
55. Almeida-Porada G, Porada CD, Chamberlain J, et al. Formation of human hepatocytes by human hematopoietic stem cells in sheep. Blood 2004;104:2582-90. (Pubitemid 39331864)
56. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-34.
57. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multilineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-77. (Pubitemid 32455343)
58. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003;422:901-4. (Pubitemid 36520043)
59. Jang YY, Collector MI, Baylin SB, et al. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004;6:532-9. (Pubitemid 38786596)
60. Brezillon N, Lambert-Blot M, Morosan S, et al. Transplanted hepatocytes over-expressing FoxM1B efficiently repopulate chronically injured mouse liver independent of donor age. Mol Ther 2007;15:1710-15. (Pubitemid 47289015)
61. De Kock J, Ceelen L, De Spiegelaere W, et al. Simple and quick method for whole-liver decellularization: a novel in vitro threedimensional bioengineering tool? Arch Toxicol 2011;85:607-12.
62. Ricordi C, Lacy PE, Finke EH, et al. Automated method for isolation of human pancreatic islets. Diabetes 1988;37:413-20. (Pubitemid 18096377)
63. Bellin MD, Kandaswamy R, Parkey J, et al. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant 2008;8:2463-70.
64. Merani S, Shapiro AM. Current status of pancreatic islet transplantation. Clin Sci (Lond) 2006;110:611-25. (Pubitemid 43844731)
65. Ricordi C, Strom TB. Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol 2004;4:259-68. (Pubitemid 38478661)
66. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-8. (Pubitemid 30490390)
67. Poggioli R, Faradji RN, Ponte G, et al. Quality of life after islet transplantation. Am J Transplant 2006;6:371-8. (Pubitemid 43382174)
68. Noguchi H. Production of pancreatic beta-cells from stem cells. Curr Diabetes Rev 2010;6:184.
69. Aguayo-Mazzucato C, Bonner-Weir S. Stem cell therapy for type 1 diabetes mellitus. Nat Rev Endocrinol 2010;6:139-48.
70. Guo T, Hebrok M. Stem cells to pancreatic beta-cells: new sources for diabetes cell therapy. Endocr Rev 2009;30:214-27.
71. Borowiak M, Melton DA. How to make beta cells? Curr Opin Cell Biol 2009;21:727-32.
72. Kordowich S, Mansouri A, Collombat P. Reprogramming into pancreatic endocrine cells based on developmental cues. Mol Cell Endocrinol 2010;323:62-9.
73. Mishra PK, Singh SR, Joshua IG, et al. Stem cells as a therapeutic target for diabetes. Front Biosci 2010;15:461-77.
74. Hori Y. Insulin-producing cells derived from stem/progenitor cells: therapeutic implications for diabetes mellitus. Med Mol Morphol 2009;42:195-200.
75. Sikkens EC, Cahen DL, Kuipers EJ, et al. Pancreatic enzyme replacement therapy in chronic pancreatitis. Best Pract Res Clin Gastroenterol 2010;24:337-47.
76. Meier JJ, Bhushan A, Butler AE, et al. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 2005;48:2221-8. (Pubitemid 41618910)
77. Meier JJ, Lin JC, Butler AE, et al. Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 2006;49:1838-44. (Pubitemid 44025038)
78. Voltarelli JC, Couri CE, Stracieri AB, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007;297:1568-76. (Pubitemid 46588370)
79. Pasquali L, Fan Y, Trucco M, et al. Rehabilitation of adaptive immunity and regeneration of beta cells. Trends Biotechnol 2006;24:516-22. (Pubitemid 44559695)
80. Dor Y, Brown J, Martinez OI, et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004;429:41-6. (Pubitemid 38620543)
81. Xu X, D'Hoker J, Stangé G, et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008;132:197-207. (Pubitemid 351181232)
82. Seaberg RM, Smukler SR, Kieffer TJ, et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 2004;22:1115-24. (Pubitemid 39166849)
83. Smukler SR, Arntfield ME, Razavi R, et al. The adult mouse and human pancreas contain Rare multipotent stem cells that express insulin. Cell Stem Cell 2011;8:281-93.
84. Thorel F, Népote V, Avril I, et al. Conversion of adult pancreatic [agr]-cells to [bgr]-cells after extreme [bgr]-cell loss. Nature 2010;464:1149-54.
85. Martin-Pagola A, Sisino G, Allende G, et al. Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity. Diabetologia 2008;51:1803-13.
86. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7. (Pubitemid 28516247)
87. D'Amour KA, Agulnick AD, Eliazer S, et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005;23:1534-41. (Pubitemid 41752931)
88. D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006;24:1392-401. (Pubitemid 44722103)
89. Lumelsky N, Blondel O, Laeng P, et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389-94. (Pubitemid 32476228)
90. Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucoseresponsive insulin-secreting cells in vivo. Nat Biotechnol 2008;26:443-52. (Pubitemid 351501814)
91. Fujikawa T, Oh SH, Pi L, et al. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cellderived insulin-producing cells. Am J Pathol 2005;166:1781-91. (Pubitemid 40734401)
92. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72. (Pubitemid 350138099)
93. Yu J, Hu K, Smuga-Otto K, et al. Induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324:797-801.
94. Jia F, Wilson KD, Sun N, et al. A nonviral minicircle vector for deriving human iPS cells. Nat Methods 2010;7:197-9.
95. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-20.
96. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009;4:472-6.
97. Tateishi K, He J, Taranova O, et al. Generation of insulinsecreting islet-like clusters from human skin fibroblasts. J Biol Chem 2008;283:31601-7.
98. Alipio Z, Liao W, Roemer EJ, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci U S A 2010;107:13426-31.
99. Hussein SM, Batada NN, Vuoristo S, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011;471:58-62.
100. Pera MF. Stem cells: the dark side of induced pluripotency. Nature 2011;471:46-7.
101. Deng J, Shoemaker R, Xie B, et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 2009;27:353-60.
102. Gore A, Li Z, Fung HL, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011;471:63-7.
103. Feng Q, Lu SJ, Klimanskaya I, et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 2010;28:704-12.
104. Lee SH, Hao E, Savinov AY, et al. Human beta-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies. Transplantation 2009;87:983-91.
105. Fort A, Fort N, Ricordi C, et al. Biohybrid devices and encapsulation technologies for engineering a bioartificial pancreas. Cell Transplant 2008;17:997-1003.
106. Furth ME, Atala A. Stem cell sources to treat diabetes. J Cell Biochem 2009;106:507-11.
107. Kadam SS, Bhonde RR. Islet neogenesis from the constitutively nestin expressing human umbilical cord matrix derived mesenchymal stem cells. Islets 2010;2:112-20.
108. Le Douarin NM, Creuzet S, Couly G, et al. Neural crest cell plasticity and its limits. Development 2004;131:4637-50. (Pubitemid 39433452)
109. Huang CY, Pelaez D, Dominguez-Bendala J, et al. Plasticity of stem cells derived from adult periodontal ligament. Regen Med 2009;4:809-21.
110. Kang HM, Kim J, Park S, et al. Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice. Stem Cells 2009;27:1999-2008.
111. Paredes B, Santana A, Arribas MI, et al. Phenotypic differences during the osteogenic differentiation of single-cell derived clones isolated from human lipoaspirates. J Tissue Eng Regen Med 2011;5:589-99.
112. Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008;455:627-32.
113. Aramata S, Han SI, Kataoka K. Roles and regulation of transcription factor MafA in islet beta-cells. Endocr J 2007;54:659-66. (Pubitemid 351377742)
114. Zhao L, Guo M, Matsuoka TA, et al. The islet beta cell-enriched MafA activator is a key regulator of insulin gene transcription. J Biol Chem 2005;280:11887-94. (Pubitemid 40418503)
115. Kaneto H, Matsuoka TA, Nakatani Y, et al. A crucial role of MafA as a novel therapeutic target for diabetes. J Biol Chem 2005;280:15047-52. (Pubitemid 40562858)
116. Opara EC, Mirmalek-Sani SH, Khanna O, et al. Design of a bioartificial pancreas. J Investig Med 2010;58:831-7.
117. Chatenoud L, You S, Okada H, et al. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis. Clin Exp Immunol 2010;160:106-12.
118. Koch KL. Gastric neuromuscular function and neuromuscular disorders. In: Feldman M, Friedman LS, Brandt LJ, eds. Gastrointestinal and Liver Diseases. Philadelphia: Saunders, 2010:789-815.
119. Hecker L, Baar K, Dennis RG, et al. Development of a threedimensional physiological model of the internal anal sphincter bioengineered in vitro from isolated smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2005;289:G188-96. (Pubitemid 41022743)
120. Somara S, Gilmont RR, Dennis RG, et al. Bioengineered internal anal sphincter derived from isolated human internal anal sphincter smooth muscle cells. Gastroenterology 2009;137:53-61.
121. Raghavan S, Miyasaka EA, Hashish M, et al. Successful implantation of physiologically functional bioengineered mouse internal anal sphincter. Am J Physiol Gastrointest Liver Physiol 2010;299:G430-9.
122. Lee M, Wu BM, Stelzner M, et al. Intestinal smooth muscle cell maintenance by basic fibroblast growth factor. Tissue Eng Part A 2008;14:1395-402.
123. Miyasaka EA, Raghavan S, Gilmont RR, et al. In vivo growth of a bioengineered internal anal sphincter: comparison of growth factors for optimization of growth and survival. Pediatr Surg Int 2011;27:137-43.
124. Ashton GH, Morton JP, Myant K, et al. Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling. Dev Cell 2010;19:259-69.
125. Mashanov VS, Garci ́a-Arrarás JE. Gut regeneration in holothurians: a snapshot of recent developments. Biol Bull 2011;221:93-109.
126. Freud E, Efrati I, Kidron D, et al. Comparative experimental study of esophageal wall regeneration after prosthetic replacement. J Biomed Mater Res 1999;45:84-91. (Pubitemid 29114155)
127. Nakase Y, Nakamura T, Kin S, et al. Intrathoracic esophageal replacement by in situ tissue-engineered esophagus. J Thorac Cardiovasc Surg 2008;136:850-9.
128. Badylak SF, Hoppo T, Nieponice A, et al. Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A 2011;17:1643-50.
129. Hori Y, Nakamura T, Kimura D, et al. Functional analysis of the tissue-engineered stomach wall. Artif Organs 2002;26:868-72. (Pubitemid 36005547)
130. Speer AL, Sala FG, Matthews JA, et al. Murine tissueengineered stomach demonstrates epithelial differentiation. J Surg Res 2011;171:6-14.
131. Sala FG, Kunisaki SM, Ochoa ER, et al. Tissue-engineered small intestine and stomach form from autologous tissue in a preclinical large animal model. J Surg Res 2009;156:205-12.
132. Maemura T, Shin M, Sato M, et al. A tissue-engineered stomach as a replacement of the native stomach. Transplantation 2003;76:61-5. (Pubitemid 36877116)
133. Maemura T, Shin M, Kinoshita M, et al. A tissue-engineered stomach shows presence of proton pump and G-cells in a rat model, resulting in improved anemia following total gastrectomy. Artif Organs 2008;32:234-9. (Pubitemid 351326758)
134. Chen MK, Badylak SF. Small bowel tissue engineering using small intestinal submucosa as a scaffold. J Surg Res 2001;99:352-8. (Pubitemid 32703459)
135. Gilmont RR, Somara S, Srinivasan S, et al. IAS smooth muscle cells direct the differentiation of neuronal progenitor cells into mature neurons. Gastroenterology 2011;141:310-19.
136. Raghavan S, Gilmont RR, Miyaska EA, et al. Successful implantation of bioengineered, intrinsically innervated human internal anal sphincter. Gastroenterology 2011;141:310-19.